Mass General Hospital

Harvard Medical School

Tag Archives | reproductive safety

Good News: More Data on the Use of ADHD Medications During Pregnancy

For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we often recommend discontinuing stimulant medications and switching to a non-pharmacologic intervention.  Many women experience some decrease in their level of functioning; however, they are able to forgo or minimize pharmacologic treatment during pregnancy.  There are, however, women who experience more severe symptoms which interfere […]

Continue Reading · 0

Is It Safe During Pregnancy? There’s An App for That

  January was Birth Defects Prevention Month, and MotherToBaby launched a free app  designed to provide evidence-based information to pregnant and breastfeeding women. There is Information on a broad range of medications, some herbal remedies, maternal illness, infections and vaccines, alcohol and other substances, occupational exposures, and other exposures (including things like lead, hair dye). […]

Continue Reading · 0

New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data on the reproductive safety of these newer atypical agents. In response to this deficit, the National Pregnancy Registry for Atypical […]

Continue Reading · 0

New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data on the reproductive safety of these newer atypical agents. In response to this deficit, the National Pregnancy Registry for Atypical […]

Continue Reading · 1
Credit: Hugrekk via flickr https://www.flickr.com/photos/hugrekki/2347830057/in/dateposted/

New Research from the CWMH: Complementary Therapies Commonly Taken by Pregnant Women with Psychiatric Illness

When I recently reviewed the stats for our website, I was surprised when I looked at the most frequently visited posts.  I was expecting to find at the top of the list one of our posts on antidepressants and pregnancy or perhaps a post on postpartum depression.  Nope, I was way off.  Our most popular […]

Continue Reading · 0
Credit: Pregnant Woman from Wikimedia Commons

New Research from the CWMH: Newer Antipsychotics and Pregnancy

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data on the reproductive safety of these newer atypical agents.  In response to this deficit, the National Pregnancy Registry for Atypical […]

Continue Reading · 0
Credit: Pregnant Woman from Wikimedia Commons

Venlafaxine and Duloxetine: Pooled Analysis Shows No Increase in Risk of Malformations

Women face difficult choices when deciding whether or not to continue psychiatric medications during pregnancy.  This choice can be especially difficult for women taking newer medications which lack adequate reproductive safety data.  While we have adequate data regarding the reproductive safety of most of the selective serotonin reuptake inhibitors (SSRIs), there has been less information […]

Continue Reading · 0
Baby Belly from Wikimedia Commons

New Research from the CWMH: Reassuring Data from the National Pregnancy Registry of Atypical Antipsychotics

Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data on the reproductive safety of these newer atypical agents.  In response to this deficit, the National Pregnancy Registry for Atypical […]

Continue Reading · 0

You Asked: Gabapentin (Neurontin) and Pregnancy

While gabapentin (Neurontin) is now used in a wide variety of clinical settings — for epilepsy, pain management, restless leg syndrome, anxiety, and sleep disturbance – there is relatively little information regarding its reproductive safety.  Most recently, a prospective study from researchers at the Motherisk program reports on the outcomes of 223 pregnancies exposed to gabapentin […]

Continue Reading · 0

Gabapentin (Neurontin) and Pregnancy

Despite the fact that gabapentin (Neurontin) is now used in a wide variety of clinical settings — for epilepsy, pain management, anxiety, sleep disturbance – there is relatively little information regarding its reproductive safety.  A prospective study from researchers at the Motherisk program reports on the outcomes of 223 pregnancies exposed to gabapentin and 223 unexposed pregnancies.

Continue Reading · 0